By Joanna Sampson2018-02-09T14:34:00
Cryogenics logistics company Cryoport, Inc., will support TiGenix as it conducts its SEPCELL phase Ib/IIa clinical study to evaluate the safety and efficacy of expanded Cx611 allogeneic adipose‐derived stem cells (eASCs) for the treatment of sepsis in adult patients with severe community‐acquired bacterial pneumonia and admitted to the intensive care ...
If you already subscribe, please sign-in now
To access hundreds of features, subscribe today! Discover the in-depth content our subscribers receive every month by reading this week’s free feature. Join gasworld and become a subscriber to access all of our content online from just $270.
Month on month, the gasworld website is the market-leading news portal for the global industrial gas sector, growing at an unprecedented rate and keeping its readers at the forefront of breaking news, insightful analysis and must-see features across the industry. Launched in 2004 and continually evolving, it is the only independent online news, views and intelligence portal for the global industrial gas community and the larger end-user markets – and home to the ever-increasing range of gasworld platforms.
To find out more about gasworld's advertising opportunities click here.